Equities

JiangSu WuZhong Pharmaceutical Development Co Ltd

600200:SHH

JiangSu WuZhong Pharmaceutical Development Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)11.05
  • Today's Change-0.18 / -1.60%
  • Shares traded27.29m
  • 1 Year change+42.40%
  • Beta--
Data delayed at least 15 minutes, as of May 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

JiangSu WuZhong Pharmaceutical Development Co Ltd, formerly Jiangsu Wuzhong Industrial Co Ltd, is a China-based company mainly engaged in pharmaceutical business. The Company's business includes pharmaceuticals, chemicals and real estate. Pharmaceutical business mainly involves pharmaceutical research, development, manufacture and sales. Chemical business mainly includes research, development, manufacture and sales of organic pigments, dyes and intermediates. Its main production varieties are used to produce reactive dyes and organic pigments. Real estate business includes commercial housing and affordable housing.

  • Revenue in CNY (TTM)2.33bn
  • Net income in CNY-95.04m
  • Incorporated1994
  • Employees1.05k
  • Location
    JiangSu WuZhong Pharmaceutical Development Co LtdNo. 988Dongfang Avenue, Wuzhong DistrictSUZHOU 215124ChinaCHN
  • Phone+86 51 266981888
  • Fax+86 51 265270086
  • Websitehttp://www.600200.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Beijing Foyou Pharma Co Ltd3.32bn507.64m7.53bn3.44k14.772.13--2.261.061.066.957.350.74823.469.58967,165.9011.50--14.81--65.14--15.37--2.99--0.0316--3.07--11.36------
Youcare Pharmaceutical Group Co Ltd4.04bn168.83m7.66bn3.18k45.302.09--1.900.37570.37578.978.130.65182.074.091,269,471.002.767.114.1511.6559.5464.144.248.071.42--0.207960.95-7.611.05-44.84-7.1623.40--
Harbin Pharmaceutical Group Co., Ltd.15.67bn449.71m7.79bn9.85k16.911.59--0.49730.18270.18276.341.951.136.353.461,590,093.003.790.741410.201.8926.3023.873.350.72941.0640.410.3930.0011.937.41-14.882.69-5.38--
JiangSu WuZhong Pharmactcl Devlpm Co Ltd2.33bn-95.04m8.00bn1.05k--4.52--3.43-0.1366-0.13663.232.480.55316.072.292,220,525.00-2.31-2.92-4.78-5.3022.4128.14-4.18-5.771.22-0.32320.5063--10.555.655.58---19.08--
Pulike Biological Engineering Inc1.18bn136.36m8.16bn1.68k59.762.98--6.900.39460.39463.397.910.3592.392.65704,310.604.147.644.818.9660.9662.5711.5317.852.58148.400.014652.481.8415.553.995.1741.5818.47
Shandong Lukang Pharmaceutical Co Ltd6.28bn267.79m8.32bn6.48k31.812.26--1.330.2920.2926.884.110.71873.546.45967,865.703.212.215.514.0523.5523.414.473.460.73135.390.468931.799.3413.0478.378.81-16.9523.94
Guangxi Wuzhou Zhongheng Group Co Ltd3.23bn156.14m8.49bn2.89k54.161.29--2.630.04540.04540.94131.910.27661.963.411,120,149.000.95422.261.513.3853.6672.053.457.272.38--0.179545.6714.10-1.266.69-32.76-4.56-30.12
Data as of May 21 2024. Currency figures normalised to JiangSu WuZhong Pharmaceutical Development Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

5.14%Per cent of shares held by top holders
HolderShares% Held
China Merchants Fund Management Co., Ltd.as of 31 Dec 202313.65m1.93%
GF Fund Management Co., Ltd.as of 31 Dec 20237.85m1.11%
SWS MU Fund Management Co., Ltd.as of 31 Dec 20235.20m0.73%
Caitong Fund Management Co., Ltd.as of 30 Jun 20232.65m0.37%
The Vanguard Group, Inc.as of 09 May 20242.05m0.29%
Peng Yang Amc Fund Management Co. Ltd.as of 30 Jun 20231.80m0.26%
China Universal Asset Management Co., Ltd.as of 31 Dec 20231.40m0.20%
Great Wall Fund Management Co., Ltd.as of 31 Dec 20231.16m0.16%
Huashang Fund Management Co., Ltd.as of 30 Jun 2023376.00k0.05%
Qianhai Alliance Asset Management Co., Ltd.as of 30 Jun 2023285.00k0.04%
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.